Tifuvirtide (also known as T 1249) is a synthetically designed hybrid retroviral envelope polypeptide patented by Trimeris, Inc. as fusion inhibitor useful for the treatment of HIV infection. Tifuvirtide binds to HIV glycoprotein 41 (gp41) and prevents its fusogenic conformation, inhibiting viral entry into host cells. Tifuvirtide is composed of sequences from HIV-1, HIV-2, and simian immunodeficiency virus. Tifuvirtide has greater potency in vitro, compared with enfuvirtide, and elicits activity against most enfuvirtide-resistant isolates in vitro and in vivo. A successful short-term phase 1/2 studies evaluation of antiretroviral activity and safety in humans proved the potential of this new drug, although further clinical development was discontinued.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15747252
192 mg/day
Route of Administration:
Other
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 08:50:34 UTC 2023
by
admin
on
Sat Dec 16 08:50:34 UTC 2023
|
Protein Type | PEPTIDE |
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
M6W86MD258
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1660
Created by
admin on Sat Dec 16 08:50:34 UTC 2023 , Edited by admin on Sat Dec 16 08:50:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70179833
Created by
admin on Sat Dec 16 08:50:34 UTC 2023 , Edited by admin on Sat Dec 16 08:50:34 UTC 2023
|
PRIMARY | |||
|
M6W86MD258
Created by
admin on Sat Dec 16 08:50:34 UTC 2023 , Edited by admin on Sat Dec 16 08:50:34 UTC 2023
|
PRIMARY | |||
|
DB05413
Created by
admin on Sat Dec 16 08:50:34 UTC 2023 , Edited by admin on Sat Dec 16 08:50:34 UTC 2023
|
PRIMARY | |||
|
16130644
Created by
admin on Sat Dec 16 08:50:34 UTC 2023 , Edited by admin on Sat Dec 16 08:50:34 UTC 2023
|
PRIMARY | |||
|
C152617
Created by
admin on Sat Dec 16 08:50:34 UTC 2023 , Edited by admin on Sat Dec 16 08:50:34 UTC 2023
|
PRIMARY | |||
|
CHEMBL2108654
Created by
admin on Sat Dec 16 08:50:34 UTC 2023 , Edited by admin on Sat Dec 16 08:50:34 UTC 2023
|
PRIMARY | |||
|
8467
Created by
admin on Sat Dec 16 08:50:34 UTC 2023 , Edited by admin on Sat Dec 16 08:50:34 UTC 2023
|
PRIMARY | |||
|
251562-00-2
Created by
admin on Sat Dec 16 08:50:34 UTC 2023 , Edited by admin on Sat Dec 16 08:50:34 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER AVERAGE(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|